TrialInternational journal of clinical oncology2018

No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.